IPF Transplant Referral — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Refer early for lung-transplant assessment while continuing antifibrotic and supportive management according to eligibility
The best answer is “Refer early for lung-transplant assessment while continuing antifibrotic and supportive management according to eligibility”. Marked physiological impairment and exertional desaturation warrant early transplant referral before further irreversible decline or deconditioning. Referral does not guarantee listing and does not require stopping antifibrotic therapy. Chronic corticosteroid monotherapy is not effective disease modification in IPF, and lung-volume-reduction surgery targets selected emphysema rather than diffuse fibrosis.
Reference: Cancer Council Australia: Clinical practice guidelines for lung cancer: https://www.cancer.org.au/health-professionals/clinical-practice-guidelines/lung-cancer Lung Foundation Australia: Pulmonary arterial hypertension: https://lungfoundation.com.au/support-resources/resource-hub/pulmonary-arterial-hypertension-fact-sheet/